Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Klett LC"'
Autor:
Piroeva KV; School of Life Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, United Kingdom., McDonald C; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, United Kingdom., Xanthopoulos C; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, United Kingdom., Fox C; School of Life Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, United Kingdom., Clarkson CT; School of Life Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, United Kingdom., Mallm JP; German Cancer Research Center (DKFZ) Heidelberg, Single Cell Open Lab, 69120 Heidelberg, Germany.; German Cancer Research Center (DKFZ) Heidelberg, Division of Chromatin Networks, 69120 Heidelberg, Germany.; Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), Heidelberg University, 69120 Heidelberg, Germany., Vainshtein Y; Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB, 70569 Stuttgart, Germany., Ruje L; School of Life Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, United Kingdom., Klett LC; German Cancer Research Center (DKFZ) Heidelberg, Division of Chromatin Networks, 69120 Heidelberg, Germany.; Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), Heidelberg University, 69120 Heidelberg, Germany., Stilgenbauer S; Division of CLL, University Hospital Ulm, Department of Internal Medicine III, 89081 Ulm, Germany., Mertens D; Division of CLL, University Hospital Ulm, Department of Internal Medicine III, 89081 Ulm, Germany.; German Cancer Research Center (DKFZ) Heidelberg, Cooperation Unit Mechanisms of Leukemogenesis, 69120 Heidelberg, Germany., Kostareli E; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7BL, United Kingdom; vteif@essex.ac.uk karsten.rippe@dkfz.de e.kostareli@qub.ac.uk., Rippe K; German Cancer Research Center (DKFZ) Heidelberg, Division of Chromatin Networks, 69120 Heidelberg, Germany; vteif@essex.ac.uk karsten.rippe@dkfz.de e.kostareli@qub.ac.uk.; Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), Heidelberg University, 69120 Heidelberg, Germany., Teif VB; School of Life Sciences, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, United Kingdom; vteif@essex.ac.uk karsten.rippe@dkfz.de e.kostareli@qub.ac.uk.
Publikováno v:
Genome research [Genome Res] 2023 Oct; Vol. 33 (10), pp. 1649-1661. Date of Electronic Publication: 2023 Sep 12.
Autor:
Muckenhuber M; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Seufert I; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Müller-Ott K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Mallm JP; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Single Cell Open Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany., Klett LC; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Knotz C; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Hechler J; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Kepper N; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Erdel F; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany karsten.rippe@dkfz.de.
Publikováno v:
Life science alliance [Life Sci Alliance] 2023 Feb 02; Vol. 6 (4). Date of Electronic Publication: 2023 Feb 02 (Print Publication: 2023).
Autor:
Hanna BS; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Electronic address: bola.hanna@hms.harvard.edu., Llaó-Cid L; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Iskar M; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Roessner PM; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Klett LC; Chromatin Networks, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Wong JKL; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Paul Y; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Ioannou N; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK., Öztürk S; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Mack N; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Kalter V; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Colomer D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hematopathology Unit, Pathology Department, Hospital Clinic, CIBERONC, University of Barcelona, 08036 Barcelona, Spain., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hematopathology Unit, Pathology Department, Hospital Clinic, CIBERONC, University of Barcelona, 08036 Barcelona, Spain., Bloehdorn J; Internal Medicine III, University of Ulm, 89081 Ulm, Germany., Stilgenbauer S; Internal Medicine III, University of Ulm, 89081 Ulm, Germany., Dietrich S; Medicine V, University Hospital Heidelberg, 69120 Heidelberg, Germany., Schmidt M; Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, 69120 Heidelberg, Germany., Gabriel R; Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, 69120 Heidelberg, Germany., Rippe K; Chromatin Networks, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Feuerer M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Chair for Immunology, Regensburg Center for Interventional Immunology (RCI), University of Regensburg, 93053 Regensburg, Germany., Ramsay AG; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK., Lichter P; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Zapatka M; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Seiffert M; Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Electronic address: m.seiffert@dkfz.de.
Publikováno v:
Immunity [Immunity] 2021 Dec 14; Vol. 54 (12), pp. 2825-2841.e10. Date of Electronic Publication: 2021 Dec 07.
Autor:
Wierzbinska JA; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; The German Cancer Consortium (DKTK), Heidelberg, Germany., Toth R; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Ishaque N; The German Cancer Consortium (DKTK), Heidelberg, Germany., Rippe K; The German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Chromatin Networks, DKFZ, Heidelberg, Germany., Mallm JP; The German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Chromatin Networks, DKFZ, Heidelberg, Germany., Klett LC; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Division of Chromatin Networks, DKFZ, Heidelberg, Germany., Mertens D; The German Cancer Consortium (DKTK), Heidelberg, Germany.; Mechanisms of Leukemogenesis, DKFZ, Heidelberg, Germany., Zenz T; Experimental Hematology Lab, University Hospital Zurich, Zurich, Switzerland., Hielscher T; Biostatistics, DKFZ, Heidelberg, Germany., Seifert M; Group Molecular Genetics, Essen University Hospital, Essen, Germany., Küppers R; Group Molecular Genetics, Essen University Hospital, Essen, Germany., Assenov Y; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Stilgenbauer S; Department of Internal Medicine, Ulm University, Ulm, Germany., Roessner PM; Division of Molecular Genetics, DKFZ, Heidelberg, Germany., Seiffert M; Division of Molecular Genetics, DKFZ, Heidelberg, Germany., Byrd J; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, USA., Oakes CC; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, USA.; Department of Biomedical Informatics, The Ohio State University, Columbus, USA., Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. c.plass@dkfz.de.; The German Cancer Consortium (DKTK), Heidelberg, Germany. c.plass@dkfz.de., Lipka DB; The German Cancer Consortium (DKTK), Heidelberg, Germany. d.lipka@dkfz.de.; Section Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. d.lipka@dkfz.de.; National Center for Tumor Diseases (NCT), Heidelberg, Germany. d.lipka@dkfz.de.; Faculty of Medicine, Medical Center, Otto-von-Guericke-University, 39120, Magdeburg, Germany. d.lipka@dkfz.de.
Publikováno v:
Genome medicine [Genome Med] 2020 Mar 18; Vol. 12 (1), pp. 29. Date of Electronic Publication: 2020 Mar 18.
Autor:
Mallm JP; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Iskar M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ishaque N; Division of Theoretical Bioinformatics and Heidelberg Center for Personalized Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Klett LC; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Kugler SJ; Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany., Muino JM; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany., Teif VB; School of Biological Sciences, University of Essex, Colchester, UK., Poos AM; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute Jena, Jena, Germany., Großmann S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Erdel F; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Centre de Biologie Intégrative (CBI), CNRS, UPS, Toulouse, France., Tavernari D; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Koser SD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schumacher S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany., Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., König R; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute Jena, Jena, Germany., Remondini D; Department of Physics and Astronomy, Bologna University, Bologna, Italy., Vingron M; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany., Stilgenbauer S; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany., Lichter P; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Zapatka M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mertens D; Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany daniel.mertens@uniklinik-ulm.de karsten.rippe@dkfz.de.; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany., Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany daniel.mertens@uniklinik-ulm.de karsten.rippe@dkfz.de.
Publikováno v:
Molecular systems biology [Mol Syst Biol] 2019 May 22; Vol. 15 (5), pp. e8339. Date of Electronic Publication: 2019 May 22.